Body weight loss was more pronounced with tirzepatide than with semaglutide (LSM estimated treatment difference, 1.9, 3.6, and 5.5 kg, respectively
Each COA documents peptide identity by HPLC and/or mass spectrometry, purity analysis, and the lot reference
They recognize that clinical trials showed modest effects (average 2.6 kg over 12 weeks in responders), appreciate that individual response varies significantly, commit to proper nutrition and exercise foundations, and accept that the peptide is used for research purposes under medical supervision
Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia/reperfusion injury: evidence for improving cardiac metabolic efficiency
adults being overweight, 4 and 40% of U.S